Webinar: Tackling Medication Adherence in Home Health & Social Care

As the UK’s population continues to age, the demand for healthcare, home care, and social care services is increasing. By 2050, the proportion of the global population aged 65 and above is expected to rise from 10% in 2022 to 16%. With this demographic shift and the growing prevalence of chronic conditions, it is essential to find effective solutions that support patients in maintaining their independence.

Medication adherence plays a crucial role in preventing avoidable hospital admissions and readmissions, supporting people to remain safely in their own homes. Good adherence not only benefits patients by improving their quality of life and independence, but also reduces pressure on the NHS and wider social care services.

Panelists:
–Robert Kennedy, Head of Operations at Kyndi Care, Medway Council UK
–Shantelle Million-Lawson, Chief Operations Officer at Technology Enabled Care Services Association (TSA)
–Eetu Koski, Chief Executive Officer at Evondos Group

Moderator:
–Maddy Dadson, Customer Success Manager at Evondos UK

Discover more about Evondos Group:

Evondos Group is Europe’s leading provider of automated medicine dispensing services. Evondos’ unique medicine dispensing service offers significant quality and cost benefits to professional home care organizations and helps societies to provide home care with effective use of resources. The service ensures that home care clients receive the correct medication at the right time and in the appropriate dosage automatically, improving medication management quality and supporting independent living at home.

In early 2023, Evondos acquired Medido, a Dutch provider of medicine dispensing services in the Netherlands, Norway, Sweden, and Denmark. Evondos Group employs today a total of 350+ professionals in the Nordic countries, the United Kingdom and the Netherlands, serving tens of thousands of users daily. The headquarters of Evondos Group is located in Helsinki, with the majority of its operations and production facilities in Salo, Finland.